Login to Your Account

Financings Roundup

Cat on a Hot Twin Proof? After Cougar, Puma Roars

By Randy Osborne
Staff Writer

Monday, October 22, 2012

Puma Biotechnology Inc.'s CEO Alan Auerbach first became widely known in 2009 for the sale of his previous firm, Cougar Biotechnology Inc., to Johnson & Johnson for $970 million, based largely on the strength of Cougar's lead compound, abiraterone.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription